Cite
Méndez-Luna D, Morelos-Garnica LA, García-Vázquez JB, et al. Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells. Pharmaceuticals (Basel). 2021;14(1)doi: 10.3390/ph14010049.
Méndez-Luna, D., Morelos-Garnica, L. A., García-Vázquez, J. B., Bello, M., Padilla-Martínez, I. I., Fragoso-Vázquez, M. J., Dueñas González, A., De Pedro, N., Gómez-Vidal, J. A., Mendoza-Figueroa, H. L., & Correa-Basurto, J. (2021). Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells. Pharmaceuticals (Basel, Switzerland), 14(1), . https://doi.org/10.3390/ph14010049
Méndez-Luna, David, et al. "Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells." Pharmaceuticals (Basel, Switzerland) vol. 14,1 (2021). doi: https://doi.org/10.3390/ph14010049
Méndez-Luna D, Morelos-Garnica LA, García-Vázquez JB, Bello M, Padilla-Martínez II, Fragoso-Vázquez MJ, Dueñas González A, De Pedro N, Gómez-Vidal JA, Mendoza-Figueroa HL, Correa-Basurto J. Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells. Pharmaceuticals (Basel). 2021 Jan 10;14(1). doi: 10.3390/ph14010049. PMID: 33435260; PMCID: PMC7826836.
Copy
Download .nbib